Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)

  • Jieun Park
  • , Eun Sol Chang
  • , Ji Yeon Kim
  • , Chaithanya Chelakkot
  • , Minjung Sung
  • , Ji Young Song
  • , Kyungsoo Jung
  • , Ji Hye Lee
  • , Jun Young Choi
  • , Na Young Kim
  • , Hyegyeong Lee
  • , Mi Ran Kang
  • , Mi Jeong Kwon
  • , Young Kee Shin
  • , Yeon Hee Park
  • , Yoon La Choi

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate. Mesenchymal-epithelial transition factor (MET). MET (MNNG-HOS transforming gene). The Original Article has been corrected.

Original languageEnglish
Article number3
JournalBreast Cancer Research
Volume27
Issue number1
DOIs
StatePublished - Dec 2025

Fingerprint

Dive into the research topics of 'Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)'. Together they form a unique fingerprint.

Cite this